InvestorsHub Logo

Bourbon_on_my_cornflakes

02/11/22 1:11 PM

#350824 RE: ignatiusrielly35 #350822

Right. Missling has ruined AVXL’s brand beyond repair. Patients will refuse to take the drug so no revenue will ever come in. LOL

Spot on! Branding is nonsense at this point, as patients and doctors don't even know 273 exists.


With approval, an effective Rett and alz treatment will get plenty of recognition and the brand will become known for the first time. The media will be giving us free articles left and right.

Spending money on marketing/rebranding now when there is no product is the most silly type of diversionary rabbit hole. No thinking person would buy it.